Liquid Biopsy Market
- Technological Advancements
- Regulatory Support
- Growing Clinical Adoption
- Rising Incidence of Cancer
Liquid Biopsy Market 시장의 주요 기업은 다음과 같습니다
향후 전망
Liquid Biopsy Market 향후 전망
보고서 범위
시장 하이라이트
FAQs
What is the current valuation of the Liquid Biopsy Market as of 2024?
What is the projected market size for the Liquid Biopsy Market by 2035?
The market is projected to reach 27.34 USD Billion by 2035.
What is the expected CAGR for the Liquid Biopsy Market during the forecast period 2025 - 2035?
Which application segment is anticipated to dominate the Liquid Biopsy Market?
The Oncology application segment is expected to grow from 4.5 USD Billion to 13.5 USD Billion by 2035.
How does the market for Non-Oncology applications compare to Prenatal Testing?
The Non-Oncology segment is projected to expand from 2.0 USD Billion to 6.0 USD Billion, while Prenatal Testing is expected to grow from 1.0 USD Billion to 3.0 USD Billion.
What are the leading sample types utilized in the Liquid Biopsy Market?
Blood is anticipated to be the leading sample type, growing from 3.5 USD Billion to 10.5 USD Billion by 2035.
Which technology segment is likely to see the most growth in the Liquid Biopsy Market?
Next Generation Sequencing is projected to increase from 2.73 USD Billion to 8.12 USD Billion during the forecast period.
What role do hospitals play in the Liquid Biopsy Market?
Hospitals are expected to grow from 2.73 USD Billion to 8.12 USD Billion, indicating their significant role as end users.
Who are the key players in the Liquid Biopsy Market?
Key players include Guardant Health, Exact Sciences, GRAIL, Freenome, and Roche Diagnostics.
What is the anticipated growth for the Diagnostic Laboratories segment?
The Diagnostic Laboratories segment is expected to grow from 2.27 USD Billion to 6.81 USD Billion by 2035.
Research Approach
Research Methodology on Liquid Biopsy Market Overview
Introduction
The research methodology for the “Liquid Biopsy Market - Global Analysis and Forecasts” report is presented in this section. This research aims to provide in-depth insights into the global liquid biopsy market, by analyzing its current and projected performance concerning competitive market forces. This report provides an overview of the industry, market drivers and inhibitors influencing the market growth, competitive dynamics and key chapters of the market in terms of market segmentation and applications.
Research Approach
In order to collect information on market trends, drivers and inhibitors, the research process includes extrapolating the data and insights derived from second-party resources such as published reports, corporate websites, and public datasets. The prognosis of the global liquid biopsy market is established by balancing the vital qualitative and quantitative information which is obtained through primary interviews with Market Experts and Thought Leaders, as well as via extensive literature reviews including secondary sources such as directories, industry journals, white papers, technical papers, press releases, corporate annual reports from top players.
Moreover, market forecasts and projections are established by using advanced econometric techniques and models. The research process is divided into five sections – Primary & Secondary Exploration, Mapping of Market Opportunities, Market Assessments & Projections and Validation of Model Assumptions.
Scope of the Report
The report includes the landscape of the global liquid biopsy market, its size by value, by region and by end-user, competitive landscape and competitive strategies adopted by key players, market dynamics such as drivers, restraints, opportunities and challenges, new technological advancements and recent launches and future market trends. The notable market players included in the report comprise Genomic Health Inc., Life Technologies Corporation, Biocept Inc., Biodesix Inc., Cepheid, Cynvenio Biosystems Inc., Exosome Life Sciences, HTG, MDxHealth Ltd., Myriad Genetics Inc., and Trovagene Inc. In all, 17 company profiles have been included in the report.
Research Methodology
The research methodology for the liquid biopsy market is based on both primary and secondary research. For the primary research, a structured questionnaire is sent to industry experts, including key opinion leaders and thought leaders, who provided their insights and views on the market. In addition, macro- and micro-economic indicators of the industry are considered for arriving at the expected market growth during the forecast period. The secondary research is done using extensive research methodologies and in-depth analysis of published market reports and content from paid databases, journals and other third-party resources. The market data is also validated with proprietary analytics tools and models.
The market is segmented into product types, applications, end-users, geographies and key countries and stakeholders. Primary interviews are conducted to ascertain the market estimates and confirm the assumptions based on secondary and primary research. The report covers a geographic segmentation of the liquid biopsy market along with competitor analysis for key countries/regions such as North America (US, Canada, Mexico and the Rest of North America), Europe (The UK, Germany, France, Rest of Europe), Asia-Pacific (India, China, Japan, Rest of Asia Pacific) and Rest of the world (Middle East & Africa, Latin America).
Market Estimation
The global liquid biopsy market is estimated considering historical data and various market dynamics such as market drivers, opportunities and challenges. Thereafter, calculated values have been derived through an exhaustive triangulation method. All these factors are studied, analyzed, considered and weighted to arrive at the estimated values, which help to forecast the market position in terms of CAGR, size and other important parameters.
Data Sources
The data points considered to come up with the market estimates and forecasts include secondary research, databases and primary research (which includes interviews and surveys). The data points were aggregated and the resultant values were checked and validated using proprietary analytics models.
Customization
The report can be customized as per the requirements of the clients. Based on detailed analysis and insights into the market, customized deliveries on the research report are provided including company-specific analysis, regional-specific analysis and segment-specific analysis.
이 보고서의 무료 샘플을 받으려면 아래 양식을 작성하십시오
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
“Thank you, this will be very helpful for OQS.”
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”